Overall and progression-free survival in endometrial carcinoma: a single-center retrospective study of patients treated between 2000-2018

被引:0
|
作者
Anfinan, Nisreen [1 ]
Sait, Khalid Hussain [1 ]
Sait, Hesham Khalid [1 ]
Alshamrani, Hanan [1 ]
机构
[1] King Abdulaziz Univ, Jeddah, Saudi Arabia
关键词
D O I
10.1136/ijgc-2024-ESGO.294
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
76
引用
收藏
页码:A154 / A155
页数:2
相关论文
共 50 条
  • [41] Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study
    Whitney B. Pope
    Xin Joe Qiao
    Hyun J. Kim
    Albert Lai
    Phioanh Nghiemphu
    Xi Xue
    Benjamin M. Ellingson
    David Schiff
    Dawit Aregawi
    Soonmee Cha
    Vinay K. Puduvalli
    Jing Wu
    Wai-Kwan A. Yung
    Geoffrey S. Young
    James Vredenburgh
    Dan Barboriak
    Lauren E. Abrey
    Tom Mikkelsen
    Rajan Jain
    Nina A. Paleologos
    Patricia Lada RN
    Michael Prados
    Jonathan Goldin
    Patrick Y. Wen
    Timothy Cloughesy
    Journal of Neuro-Oncology, 2012, 108 : 491 - 498
  • [42] Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study
    Pope, Whitney B.
    Qiao, Xin Joe
    Kim, Hyun J.
    Lai, Albert
    Nghiemphu, Phioanh
    Xue, Xi
    Ellingson, Benjamin M.
    Schiff, David
    Aregawi, Dawit
    Cha, Soonmee
    Puduvalli, Vinay K.
    Wu, Jing
    Yung, Wai-Kwan A.
    Young, Geoffrey S.
    Vredenburgh, James
    Barboriak, Dan
    Abrey, Lauren E.
    Mikkelsen, Tom
    Jain, Rajan
    Paleologos, Nina A.
    Lada, Patricia
    Prados, Michael
    Goldin, Jonathan
    Wen, Patrick Y.
    Cloughesy, Timothy
    JOURNAL OF NEURO-ONCOLOGY, 2012, 108 (03) : 491 - 498
  • [43] A Retrospective Study of Progression-Free and Overall Survival in Pediatric Medulloblastoma Based on Molecular Subgroup Classification: A Single-Institution Experience
    Jiang, Tao
    Zhang, Yuqi
    Wang, Junmei
    Du, Jiang
    Raynald
    Qiu, Xiaoguang
    Wang, Ying
    Li, Chunde
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [44] Does Gross Total Resection Improve Progression-Free and Overall Survival in Pediatric Intracranial Ependymomas? Single-Center Clinical Experience Of 61 Cases
    Narin, Firat
    Bahadir, Sinan
    Hanalioglu, Sahin
    Karakaya, Dicle
    Basar, Ibrahim
    Isikay, Ilkay
    Soylemezoglu, Figen
    Akalan, Nejat
    Bilginer, Burcak
    WORLD NEUROSURGERY, 2022, 165 : E469 - E478
  • [45] Extramedullary Multiple Myeloma Associated With Reduced Overall Survival: A Retrospective Single-Center Study
    Barkay, Ido
    Maziarz, Richard T.
    Chen, Andy I.
    Dibb, William
    Chen, Yiyi
    Scott, Emma C.
    BLOOD, 2013, 122 (21)
  • [46] Impact of Kidney Dysfunction on Overall Survival in Myeloproliferative Neoplasms: A Single-Center Retrospective Study
    Al-Shaibani, Eshrak
    Young, Taylor
    Atenafu, Eshetu
    Cheung, Verna
    Alsibai, Safwan
    Gupta, Vikas
    Maze, Dawn C.
    Davidson, Marta Beata
    Banker, Aniket
    Sibai, Hassan
    BLOOD, 2023, 142
  • [47] THE IMPACT OF FERTILITY PRESERVATION ON TREATMENT DELAY AND PROGRESSION-FREE SURVIVAL IN WOMEN WITH LYMPHOMA: A SINGLE-CENTER EXPERIENCE
    Allen, P. B.
    Pavone, M. E.
    Smith, K. N.
    Kazer, R. R.
    Rademaker, A.
    Lawson, A. K.
    Moravek, M. B.
    Confino, R.
    Gordon, L. I.
    Winter, J.
    HAEMATOLOGICA, 2016, 101 : 65 - 66
  • [48] Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients
    Feng, Yu-Min
    Feng, Chin-Wen
    Lu, Chin-Li
    Lee, Ming-Yang
    Chen, Chi-Yi
    Chen, Solomon Chih-Cheng
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (04) : 336 - 342
  • [49] Genetic Variations Associated with Overall and Progression-Free Survival in Multiple Myeloma Patients Treated with Thalidomide Combinations
    Johnson, David C.
    Gregory, Walter M.
    Dickens, Nicholas J.
    Walker, Brian A.
    Szubert, Alex J.
    Davies, Faith E.
    Durie, Brian G. M.
    Van Ness, Brian G.
    Morgan, Gareth J.
    BLOOD, 2009, 114 (22) : 177 - 177
  • [50] Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and Ceritinib
    Gainor, Justin F.
    Tan, Daniel S. W.
    De Pas, Tomasso
    Solomon, Benjamin J.
    Ahmad, Aziah
    Lazzari, Chiara
    de Marinis, Filippo
    Spitaleri, Gianluca
    Schultz, Katherine
    Friboulet, Luc
    Yeap, Beow Y.
    Engelman, Jeffrey A.
    Shaw, Alice T.
    CLINICAL CANCER RESEARCH, 2015, 21 (12) : 2745 - 2752